| # | Drug | Count |
|---|---|---|
| 0 | BISOPROLOL FUMARATE | 4 |
| 1 | EPLERENONE | 4 |
| 2 | FUROSEMIDE | 4 |
| 3 | MAGNESIUM | 4 |
| 4 | METFORMIN | 4 |
| 5 | METFORMIN ER 500 MG | 4 |
| 6 | METFORMIN ER 750 MG | 4 |
| 7 | PANTOPRAZOLE | 4 |
| 8 | SODIUM NITROPRUSSIDE | 4 |
| 9 | SODIUM NITROPRUSSIDE INJECTION | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM NITROPRUSSIDE INJECTION | 4 | 0.0135 |
| 1 | SODIUM NITROPRUSSIDE | 4 | 0.0134 |
| 2 | SODIUM THIOSULFATE | 1 | 0.0030 |
| 3 | HYDROXOCOBALAMIN | 3 | 0.0010 |
| 4 | EPLERENONE | 4 | 0.0004 |
| 5 | METHIMAZOLE | 1 | 0.0002 |
| 6 | CYANOCOBALAMIN | 1 | 0.0000 |
| 7 | EPINEPHRINE | 2 | 0.0000 |
| 8 | ATORVASTATIN CALCIUM TABLETS | 2 | 0.0000 |
| 9 | BISOPROLOL FUMARATE | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aldosterone Antagonist [EPC] | 4 |
| 1 | Loop Diuretic [EPC] | 4 |
| 2 | Antidote [EPC] | 3 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| 4 | Catecholamine [EPC] | 2 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 2 |
| 6 | alpha-Adrenergic Agonist [EPC] | 2 |
| 7 | beta-Adrenergic Agonist [EPC] | 2 |
| 8 | Anticholinergic [EPC] | 1 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Anticholinergic [EPC] | 1 | 0.0001 |
| 2 | Antidote [EPC] | 3 | 0.0001 |
| 3 | alpha-Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 4 | Catecholamine [EPC] | 2 | 0.0000 |
| 5 | Aldosterone Antagonist [EPC] | 4 | 0.0000 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Loop Diuretic [EPC] | 4 | 0.0000 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 1 | 0.0000 |